According to Eagle Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is 0,87ย โฌ. In 2022 the company made an earnings per share (EPS) of 2,67ย โฌ an increase over its 2021 EPS that were of -0,63ย โฌ.